Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;103(8):1596-1605.
doi: 10.1111/aogs.14864. Epub 2024 Jun 3.

Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population-based cohort study

Affiliations

Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population-based cohort study

Unnur Gudnadottir et al. Acta Obstet Gynecol Scand. 2024 Aug.

Abstract

Introduction: Postpartum depression is one of the most common non-obstetric postnatal complications. As the microbiome (and gut-brain axis) as well as inflammation may be involved in the mechanism, we aimed to assess if antibiotic or gastric acid inhibition use during pregnancy affects the risk of postpartum depression (clinical diagnosis and/or antidepressant use up to 1 year after childbirth).

Material and methods: This population-based cohort study used first singleton pregnancy resulting in a live birth in Sweden from 2006 to 2016. Women with history of depression were excluded. Multivariable logistic regression models were used to assess the impact of antibiotics and gastric acid inhibitors and other risk factors, presented as odds ratios (ORs) with 95% confidence intervals (CI).

Results: Overall, 29% of all 10 666 women with postpartum depression were exposed to antibiotics and 6.2% to gastric acid inhibitors, compared to, respectively, 21% and 3.2% of 613 205 women without postpartum depression. Antibiotic use during pregnancy was associated with postpartum depression (OR 1.43, 95% CI 1.37-1.49), particularly for quinolones and other antibacterials (including nitroimidazole derivatives). Gastric acid inhibition was associated with an even higher risk than antibiotics (OR 2.04, 95% CI 1.88-2.21). Both antibiotics and gastric acid inhibitors suggested higher risk with increased dose in a dose-response analysis.

Conclusions: The use of antibiotics and gastric acid inhibition drugs during pregnancy appeared to be associated with a higher risk of postpartum depression. However, it is important to consider that other predisposing factors could contribute to this increased risk, even after excluding individuals with a history of depression.

Keywords: antibiotics; anti‐acids; gastric acid inhibition; microbiome; multiple logistic regression; postnatal depression; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Risk factors for postnatal depression. Multivariable logistic regression model presented as odds ratios (ORs) with 95% confidence intervals (CIs). Model adjusted for maternal age, BMI, country of birth, parity, cohabitation with father, tobacco habits, antibiotics during pregnancy, gastric acid inhibitors during pregnancy, thyroid disease, historical stillbirth/miscarriage, delivery mode, preterm birth, Apgar score at 5 min, infant death, and congenital malformations.
FIGURE 2
FIGURE 2
Dose–response curve showing the predicted probability of postpartum depression by (left) number of days (based on the defined daily dosage per package [DDD]) and (right) number of prescriptions for antibiotics (top row) and gastric acid inhibitors (bottom row).

Similar articles

Cited by

References

    1. Wang Z, Liu J, Shuai H, et al. Mapping global prevalence of depression among postpartum women. Transl Psychiatry. 2021;11:543. - PMC - PubMed
    1. Bai Y, Li Q, Cheng KK, et al. Prevalence of postpartum depression based on diagnostic interviews: a systematic review and meta‐analysis. Depress Anxiety. 2023;2023:8403222.
    1. Rasmussen MH, Strøm M, Wohlfahrt J, Videbech P, Melbye M. Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: a population‐based cohort study. PLoS Med. 2017;14:e1002392. - PMC - PubMed
    1. Peñalver Bernabé B, Maki PM, Dowty SM, et al. Precision medicine in perinatal depression in light of the human microbiome. Psychopharmacology. 2020;237:915‐941. - PubMed
    1. Rackers HS, Thomas S, Williamson K, Posey R, Kimmel MC. Emerging literature in the microbiota‐brain Axis and perinatal mood and anxiety disorders. Psychoneuroendocrinology. 2018;95:86‐96. - PMC - PubMed

Substances